Company Name: Beigene, Ltd.
Beigene, Ltd. is a biopharmaceutical company. The company is engaged in the development of molecularly targeted and immuno-oncology therapeutics designed to treat cancer.
Ticker Symbol: BGNE (NASDAQ)
Company Website: www.beigene.com
Social Media: Beigene LinkedIn
Headquarters: Beijing, China; registered offices in Cayman Islands